Search by Drug Name or NDC

    NDC 65649-0150-06 Relistor 150 mg/1 Details

    Relistor 150 mg/1

    Relistor is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Salix Pharmaceuticals, Inc.. The primary component is METHYLNALTREXONE BROMIDE.

    Product Information

    NDC 65649-0150
    Product ID 65649-150_0c52697c-202f-6baa-e063-6294a90a2591
    Associated GPIs 52580050100320
    GCN Sequence Number 076398
    GCN Sequence Number Description methylnaltrexone bromide TABLET 150 MG ORAL
    HIC3 H3Y
    HIC3 Description MU-OPIOID RECEPTOR ANTAGONISTS,PERIPHERALLY-ACTING
    GCN 41923
    HICL Sequence Number 035611
    HICL Sequence Number Description METHYLNALTREXONE BROMIDE
    Brand/Generic Brand
    Proprietary Name Relistor
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methylnaltrexone bromide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name METHYLNALTREXONE BROMIDE
    Labeler Name Salix Pharmaceuticals, Inc.
    Pharmaceutical Class Opioid Antagonist [EPC], Opioid Antagonists [MoA], Quaternary Ammonium Compounds [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208271
    Listing Certified Through 2024-12-31

    Package

    NDC 65649-0150-06 (65649015006)

    NDC Package Code 65649-150-06
    Billing NDC 65649015006
    Package 1 BOTTLE in 1 CARTON (65649-150-06) / 6 TABLET in 1 BOTTLE
    Marketing Start Date 2016-07-19
    NDC Exclude Flag N
    Pricing Information N/A